IOVA · Iovance Biotherapeutics, Inc. · Documents
$14.42
+0.19 (+1.34%)
At close · Oct 2
Return incl. dividend (before tax)
Market Cap
$4.98B
Shares
452.97M
Volume · Oct 1
15.97M
Avg daily vol (3M)
17.77M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-09-29 | — | |
| Investor Event Transcript | 2026-09-15 | 2026-09-30 | |
| 8-K | 2026-08-06 | — | |
| 8-K | 2026-08-06 | — | |
| 10-Q | 2026-08-06 | 2026-06-30 | |
| 8-K | 2026-07-02 | 2026-06-30 | |
| 8-K | 2026-06-10 | 2026-06-04 | |
| Investor Event Transcript | 2026-06-04 | 2026-06-30 | |
| 10-Q | 2026-05-07 | 2026-03-31 | |
| 8-K | 2026-05-07 | — | |
| DEF 14A | 2026-04-28 | 2026-06-10 | |
| 8-K | 2026-03-20 | 2026-03-17 | |
| Investor Event Transcript | 2026-03-11 | 2026-03-31 | |
| 8-K | 2026-02-24 | — | |
| 10-K | 2026-02-24 | 2025-12-31 | |
| 8-K | 2026-01-09 | — | |
| 8-K | 2025-11-06 | — | |
| 10-Q | 2025-11-06 | 2025-09-30 | |
| 8-K | 2025-08-29 | — | |
| 8-K | 2025-08-22 | — | |
| 8-K | 2025-08-19 | 2025-08-18 | |
| 10-Q | 2025-08-07 | 2025-06-30 | |
| 8-K | 2025-08-07 | — | |
| 8-K | 2025-07-15 | — | |
| 8-K | 2025-07-03 | 2025-06-30 | |
| 8-K | 2025-06-13 | 2025-06-10 | |
| 8-K | 2025-06-10 | — | |
| 10-Q | 2025-05-08 | 2025-03-31 | |
| 8-K | 2025-05-08 | — | |
| DEF 14A | 2025-04-28 | 2025-06-10 | |
| 10-K | 2025-02-27 | 2024-12-31 | |
| 8-K | 2025-02-27 | — | |
| 8-K | 2025-02-10 | — | |
| 8-K | 2024-11-21 | 2024-11-15 | |
| 8-K | 2024-11-08 | 2024-11-07 | |
| 10-Q | 2024-11-07 | 2024-09-30 | |
| 8-K | 2024-11-07 | — | |
| 8-K | 2024-08-09 | 2024-08-08 | |
| 10-Q | 2024-08-08 | 2024-06-30 | |
| 8-K | 2024-08-08 | — | |
| 8-K | 2024-06-28 | — | |
| 8-K | 2024-06-11 | — | |
| 8-K | 2024-06-03 | 2024-05-31 | |
| 8-K | 2024-05-24 | 2024-05-23 | |
| 8-K | 2024-05-09 | — | |
| 10-Q | 2024-05-09 | 2024-03-31 | |
| DEF 14A | 2024-04-29 | 2024-06-11 | |
| 8-K | 2024-04-03 | — | |
| 8-K | 2024-03-29 | 2024-03-26 | |
| 8-K | 2024-03-04 | — |
Showing 1–50 of 146 filings